Merck
Update in progressMRK (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - General
Merck & Co., Inc. is a global healthcare company based in Rahway, New Jersey. It develops and markets human health medicines and vaccines, including Keytruda, Gardasil, Pneumovax, Januvia/Janumet, Bravecto, and additional therapies. The company also offers veterinary vaccines, livestock and companion-animal health products, and health-management services. It collaborates with Daiichi Sankyo, AstraZeneca, LaNova, Eisai, Bayer, Ridgeback, Infinimmune, and Moderna.
Company score
- Sentiment
- 1.29
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.39
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.83
- Governance
- -0.31
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.31
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.80
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNYSE (NYQ)
- LocationUnited States
- CEOMr. Robert M. Davis J.D.
- Founded1891
- Employees73,000
- Websitewww.merck.com
Identifiers
- ISINUS58933Y1055
- FIGIBBG000BPD168
- LEIMZK1AT00SJV4XB7WNL71
- CUSIP589331107
- CIK0000310158